From Name:
From Email:
To Name:
To Email:

Optional Message:

Opening the Door For Medical Innovation

from 04/24/17, U.S. News & World Report

The Food and Drug Administration announced on April 6 that it will allow the California-based genomics and biotechnology company 23andMe to sell direct-to-consumer tests for 10 genetic risks, including Parkinson's, late-onset Alzheimer's, Celiac and Gaucher type 1 diseases. Having this information may help customers prolong their lives, improve well-being and alleviate health-related costs. more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063